4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001209191-23-054904
10% owner bought 454,545 shares at $11.00 ($4,999,995)
- 10% owner acquired 2,112,555 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Longitude Capital Partners IV, LLC 10% owner | 2023-11-07 | Conversion | +1,793,429 | 1,793,429 | I: show line 1 in the form | ||
| Longitude Capital Partners IV, LLC 10% owner | 2023-11-07 | Conversion | +319,126 | 2,112,555 | I: show line 2 in the form | ||
| Longitude Capital Partners IV, LLC 10% owner | 2023-11-07 | Purchase | +454,545 | $11.00 | $4,999,995 | 2,567,100 | I: show line 3 in the form |
| Open-market purchases · 454,545 sh · avg $11.00 · $4,999,995 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Longitude Capital Partners IV, LLC 10% owner | 2023-11-07 | Conversion · Series A convertible preferred stock | −18,999,999 | 0 | I: show line 4 in the form | ||
| Longitude Capital Partners IV, LLC 10% owner | 2023-11-07 | Conversion · Series B convertible preferred stock | −2,906,148 | 0 | I: show line 5 in the form |
Loading xslF345X05/doc4.xml…